Francesco Torino

4.0k total citations · 1 hit paper
95 papers, 3.0k citations indexed

About

Francesco Torino is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Francesco Torino has authored 95 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Oncology, 22 papers in Pulmonary and Respiratory Medicine and 17 papers in Molecular Biology. Recurrent topics in Francesco Torino's work include Cancer Immunotherapy and Biomarkers (16 papers), Cancer Treatment and Pharmacology (12 papers) and Colorectal Cancer Treatments and Studies (11 papers). Francesco Torino is often cited by papers focused on Cancer Immunotherapy and Biomarkers (16 papers), Cancer Treatment and Pharmacology (12 papers) and Colorectal Cancer Treatments and Studies (11 papers). Francesco Torino collaborates with scholars based in Italy, United States and Poland. Francesco Torino's co-authors include Salvatore Maria Corsello, Agnese Barnabei, Roberto Salvatori, Liana De Vecchis, Massimo Libra, Paolo Marchetti, Luca Falzone, Raffaele Longo, Giampietro Gasparini and Rossella Salemi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Francesco Torino

91 papers receiving 2.9k citations

Hit Papers

Gut Microbiota and Cancer: From Pathogenesis to Therapy 2019 2026 2021 2023 2019 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francesco Torino Italy 25 1.4k 985 439 392 359 95 3.0k
Yahiya Y. Syed New Zealand 36 1.0k 0.7× 1.3k 1.3× 519 1.2× 397 1.0× 257 0.7× 107 3.8k
Cody J. Peer United States 33 1.5k 1.1× 1.8k 1.8× 559 1.3× 204 0.5× 351 1.0× 156 4.0k
Hans Loibner Austria 31 1.2k 0.9× 1.3k 1.3× 383 0.9× 197 0.5× 391 1.1× 106 4.0k
Lionel D. Lewis United States 36 1.7k 1.2× 1.4k 1.5× 806 1.8× 252 0.6× 445 1.2× 167 4.2k
Liping Du China 34 581 0.4× 897 0.9× 498 1.1× 405 1.0× 510 1.4× 172 4.0k
Timothy W. Synold United States 39 2.3k 1.6× 2.4k 2.5× 651 1.5× 246 0.6× 509 1.4× 194 5.9k
Cheng‐Ping Yu Taiwan 34 848 0.6× 1.3k 1.3× 765 1.7× 774 2.0× 535 1.5× 163 3.6k
David L. Cutler United States 31 888 0.6× 938 1.0× 544 1.2× 737 1.9× 344 1.0× 145 3.9k
Michael C. Cox United States 23 710 0.5× 492 0.5× 746 1.7× 352 0.9× 237 0.7× 53 2.7k
Gareth J. Veal United Kingdom 32 1.0k 0.7× 1.3k 1.3× 570 1.3× 310 0.8× 289 0.8× 136 3.7k

Countries citing papers authored by Francesco Torino

Since Specialization
Citations

This map shows the geographic impact of Francesco Torino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesco Torino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesco Torino more than expected).

Fields of papers citing papers by Francesco Torino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesco Torino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesco Torino. The network helps show where Francesco Torino may publish in the future.

Co-authorship network of co-authors of Francesco Torino

This figure shows the co-authorship network connecting the top 25 collaborators of Francesco Torino. A scholar is included among the top collaborators of Francesco Torino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesco Torino. Francesco Torino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Corsello, Andrea, Rosa Maria Paragliola, Francesco Torino, & Roberto Salvatori. (2025). Hypophysitis Associated with Immune Checkpoint Inhibitors. Endocrinology and Metabolism Clinics of North America. 54(4). 685–702.
2.
Younas, Ahtisham, et al.. (2025). Factors associated with self-care in adults with cancer receiving oral anticancer agents: A sex-stratified Bayesian analysis. European Journal of Oncology Nursing. 79. 103019–103019.
3.
Durante, Ángela, et al.. (2025). Validity and Reliability of the Self‐Care of Chronic Illness Inventory and Self‐Care Self‐Efficacy Scale in Patients Living With Cancer. Journal of Advanced Nursing. 81(12). 8620–8632. 2 indexed citations
5.
Durante, Ángela, et al.. (2024). Predictors of self-care in patients with cancer treated with oral anticancer agents: A systematic review. PLoS ONE. 19(9). e0307838–e0307838. 3 indexed citations
6.
Riondino, Silvia, et al.. (2023). Antibody–Drug Conjugates for the Treatment of Renal Cancer: A Scoping Review on Current Evidence and Clinical Perspectives. Journal of Personalized Medicine. 13(9). 1339–1339. 8 indexed citations
7.
Torino, Francesco, et al.. (2023). Caregivers’ contribution to self-care for patients treated with oral anticancer agents: A qualitative descriptive study. European Journal of Oncology Nursing. 64. 102327–102327. 4 indexed citations
8.
Paragliola, Rosa Maria, Francesco Torino, Agnese Barnabei, et al.. (2023). Bone Metabolism Effects of Medical Therapy in Advanced Renal Cell Carcinoma. Cancers. 15(2). 529–529. 4 indexed citations
9.
Riondino, Silvia, Vincenzo Formica, Cristina Morelli, et al.. (2023). Obesity and Breast Cancer: Interaction or Interference with the Response to Therapy?. Current Oncology. 30(1). 1220–1231. 8 indexed citations
11.
Biagioli, Valentina, Ángela Durante, Francesco Torino, et al.. (2023). Development and Content Validity of the Self-Care of Oral Anticancer Agents Index (SCOAAI). Seminars in Oncology Nursing. 39(3). 151402–151402. 5 indexed citations
12.
Morelli, Cristina, Silvia Riondino, Daniela Fraboni, et al.. (2022). Immune Response in Vitamin D Deficient Metastatic Colorectal Cancer Patients: A Player That Should Be Considered for Targeted Vitamin D Supplementation. Cancers. 14(11). 2594–2594. 7 indexed citations
13.
Iannantuono, Giovanni Maria, et al.. (2022). Activity of ALK Inhibitors in Renal Cancer with ALK Alterations: A Systematic Review. International Journal of Molecular Sciences. 23(7). 3995–3995. 19 indexed citations
14.
Iannantuono, Giovanni Maria, et al.. (2022). The Role of Histology-Agnostic Drugs in the Treatment of Metastatic Castration-Resistant Prostate Cancer. International Journal of Molecular Sciences. 23(15). 8535–8535. 13 indexed citations
15.
Riondino, Silvia, et al.. (2022). MiRNAs and circRNAs for the Diagnosis of Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients: A Narrative Review. Journal of Personalized Medicine. 12(7). 1059–1059. 8 indexed citations
16.
Biagioli, Valentina, et al.. (2022). Self-care behaviors in patients with cancer treated with oral anticancer agents: a systematic review. Supportive Care in Cancer. 30(10). 8465–8483. 10 indexed citations
17.
Biagioli, Valentina, et al.. (2022). Self-care behaviours in older adults treated with oral anticancer agents: A qualitative descriptive study. European Journal of Oncology Nursing. 58. 102139–102139. 8 indexed citations
18.
Corsi, Francesca, Stefania Briganti, Emanuele Bruni, et al.. (2022). Apoptosis as Driver of Therapy-Induced Cancer Repopulation and Acquired Cell-Resistance (CRAC): A Simple In Vitro Model of Phoenix Rising in Prostate Cancer. International Journal of Molecular Sciences. 23(3). 1152–1152. 21 indexed citations
19.
Paragliola, Rosa Maria, Francesco Torino, Vanda Salutari, et al.. (2013). “Occult” ovarian Leydig cell tumor: when laboratory tells more than imaging. Endocrine. 46(2). 351–354. 4 indexed citations
20.
Gasparini, Giampietro, Massimo Gion, Luigi Mariani, et al.. (2006). Randomized Phase II Trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancer. Breast Cancer Research and Treatment. 101(3). 355–365. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026